Forepont Capital Partners — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Exeliom Biosciencesexeliombio.cominOct 2025
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis).
BiotechDeep TechDigital HealthMedical DevicesParis, FR
Harry Sokol(Scientific Co-founder)in
Co-investorsBpifranceAgoranovAuriga PartnersUI Investissement
Okeirookeiro.cominApr 2025
Okeiro is a medical platform using predictive algorithms to monitor transplant and chronic disease patients.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsAlvenRed River West
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.